FDA hits Abbott FreeStyle Libre 3 recall with Class I tag
The US Food and Drug Administration (FDA) has tagged Abbott’s recent recall of its faulty FreeStyle Libre 3 sensors as Class ...
medtechdive4d
Abbott ramps up Libre 3 production amid shortages
Some people are facing delays in filling prescriptions for the glucose sensor. Abbott expects to resolve the problem soon.
drugdeliverybusiness6d
Class action suit targets Abbott FreeStyle Libre amid claims of data sharing
Abbott (NYSE:ABT) faces a proposed class action lawsuit related to alleged tracking tools used with its FreeStyle Libre ...
MedPage Today on MSN15d
FreeStyle Libre 3 Sensor Class I Recall; Second OTC CGM Cleared; Weekly Insulin Win
Abbott launched an over-the-counter continuous glucose monitoring system, Lingo, for adults not on insulin -- the second such ...
Hosted on MSN10mon
5 best continuous glucose monitors for diabetics: Track your blood sugar levels with ease
These devices can help you assess the condition throughout ... Data can be captured by the FreeStyle Libre Reader even through clothes when it is between 1 and 4 cm from the sensor. The FreeStyle ...
The Bryan Times15d
Certain FreeStyle Libre 3 sensors recalled due to risk for inaccurate high glucose readings
Abbott Diabetes Care, Inc. is recalling its FreeStyle Libre 3 sensors after finding a small number of the sensors may provide incorrect high glucose readings, which, if undetected may pose ...
Abbott Laboratories' Best Segment Just Got Even Better: Is the Stock a Buy?
Abbott Laboratories' (NYSE: ABT) business has been a bit of a roller coaster. The pandemic disrupted its medical device ...